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Malaria is a major disease of public health impor-
tance with a high morbidity and mortality. In endemic
regions, malaria can present with unusual features due to
development of immunity, increasing resistance to anti-
malarial drugs, and the indiscriminate use of antimalarial
drugs1. Such unusual presentations of malaria can lead to
delayed diagnosis and complications. We herein report a
girl with vivax malaria presenting with skin rash.
Case report: A 9-yr old Indian girl presented with skin
rash and fever for 2 days. Fever was high grade, continu-
ous and was associated with chills and rigors. There was
no history of any cough, cold, drug intake, abdominal pain,
vomiting, bleeding manifestations, diarrhoea or urinary
complaints. On admission she had a heart rate of 104/min
respiratory rate of 24/min and blood pressure of 104/70
mmHg. Throat examination was normal. Pallor was
present. Skin examination revealed multiple erythematous
and papular skin lesions involving bilateral upper and lower
limb (Fig. 1). Lesions were mildly itchy. Oral mucosa was
normal. Liver was palpable 2 cm below the right costal
margin with a span of 6 cm. Spleen was palpable 1 cm
below the left costal margin. Other systemic examination
was normal.  Investigations done on the day of admission
revealed: hemoglobin 8.2 g/dL, total leukocyte count
11,200/mm3, and platelet count 1.7 lac/mm3. Peripheral
blood smear showed trophozoites of P. vivax.  OptiMal
test was positive for vivax malaria. Dengue NS1 antigen
test and dark ground microscopy for leptospira were nega-
tive. Her liver function tests, renal function tests, serum
electrolytes and urine microscopy were normal. She was
treated with chloroquine along with antihistamine. Rash
disappeared completely on the third day of admission. The
patient was given primaquine for 14 days for radical cure.
She is well on follow up after six months.
Cutaneous lesions in malaria are rarely reported and
include urticaria, erythema, angioedema, petechiae, pur-
pura, and disseminated intravascular coagulation2. Cuta-
neous lesions have been described with both falciparum
and vivax malaria2. Although the exact pathogenesis of
skin lesions in malaria is not known, these may reflect
part of different immunological consequences during ma-
larial infection.  Mast cell activation plays a central role
in the pathophysiology of malaria3. Degranulation of mast
cells during various stages of malarial infection releases a
constellation of mediators like histamine, serotonin, hep-
arin, proteoglycans, prostaglandins, leukotrienes, platelet
activating factor (PAF), cytokines and tumor necrosis fac-
tor2. These mediators cause increased vascular permeability
and vasodilatation. PAF causes aggregation of human
platelets, wheal and flare response with late phase
erythema. Leukotriene-induced wheal-flare response is
long lasting and associated with endothelial activation and
up-regulation of adhesion molecules4,5. Both IgG and IgE
containing immune complexes are elevated in malaria and
probably play a role in pathogenesis6. IgE containing im-
mune complexes are associated with complicated malarial
infection. Deposition of such immune complexes in cuta-
Fig. 1: Clinical photograph showing multiple discrete erythematous
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neous vessels may result in local vasculitic damage and
skin lesions. Thus, urticaria and erythema are usually due
to histamine and/or other mediators like platelet activat-
ing factor (PAF) and leukotrienes. Purpura and petechiae
may be a result of thrombocytopenia, cytoadherance, lo-
cal vasculitis and vessel damage from immune complex
injury2. Maheshwari and Gupta have reported nine cases
of malaria presenting with urticaria as the initial feature7.
The urticaria subsided in all these patients within 12–48 h
of starting antimalarial treatment. Urticaria was attrib-
uted to direct effect of parasite on mast cells releasing
histamine, involvement of complement system, and intense
elevation of IgG antibodies.
Although the cutaneous lesions in malaria are not spe-
cific, but when associated with systemic features includ-
ing peripheral smear can help in the diagnosis of malaria.
In conclusion, physicians, especially those in endemic ar-
eas, should be aware of the varied manifestations so that
the diagnosis and treatment are timely and morbidity and
mortality minimized.
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